1icv: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /><applet load="1icv" size="450" color="white" frame="true" align="right" spinBox="true" caption="1icv, resolution 2.4Å" /> '''THE STRUCTURE OF ESCH...
 
No edit summary
Line 1: Line 1:
[[Image:1icv.jpg|left|200px]]<br /><applet load="1icv" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1icv.jpg|left|200px]]<br /><applet load="1icv" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1icv, resolution 2.4&Aring;" />
caption="1icv, resolution 2.4&Aring;" />
'''THE STRUCTURE OF ESCHERICHIA COLI NITROREDUCTASE COMPLEXED WITH NICOTINIC ACID'''<br />
'''THE STRUCTURE OF ESCHERICHIA COLI NITROREDUCTASE COMPLEXED WITH NICOTINIC ACID'''<br />


==Overview==
==Overview==
Escherichia coli nitroreductase is a flavoprotein that reduces a variety, of quinone and nitroaromatic substrates. Its ability to convert relatively, non-toxic prodrugs such as CB1954 (5-[aziridin-1-yl]-2,4-dinitrobenzamide), into highly cytotoxic derivatives has led to interest in its potential for, cancer gene therapy. We have determined the structure of the enzyme bound, to a substrate analogue, nicotinic acid, from three crystal forms at, resolutions of 1.7 A, 1.8 A and 2.4 A, representing ten, non-crystallographically related monomers. The enzyme is dimeric, and has, a large hydrophobic core; each half of the molecule consists of a, five-stranded beta-sheet surrounded by alpha-helices. Helices F and F, protrude from the core region of each monomer. There is an extensive dimer, interface, and the 15 C-terminal residues extend around the opposing, monomer, contributing the fifth beta-strand. The active sites lie on, opposite sides of the molecule, in solvent-exposed clefts at the dimer, interface. The FMN forms hydrogen bonds to one monomer and hydrophobic, contacts to both; its si face is buried. The nicotinic acid stacks between, the re face of the FMN and Phe124 in helix F, with only one hydrogen bond, to the protein. If the nicotinamide ring of the coenzyme NAD(P)H were in, the same position as that of the nicotinic acid ligand, its C4 atom would, be optimally positioned for direct hydride transfer to flavin N5., Comparison of the structure with unliganded flavin reductase and NTR, suggests reduced mobility of helices E and F upon ligand binding. Analysis, of the structure explains the broad substrate specificity of the enzyme, and provides the basis for rational design of novel prodrugs and for, site-directed mutagenesis for improved enzyme activity.
Escherichia coli nitroreductase is a flavoprotein that reduces a variety of quinone and nitroaromatic substrates. Its ability to convert relatively non-toxic prodrugs such as CB1954 (5-[aziridin-1-yl]-2,4-dinitrobenzamide) into highly cytotoxic derivatives has led to interest in its potential for cancer gene therapy. We have determined the structure of the enzyme bound to a substrate analogue, nicotinic acid, from three crystal forms at resolutions of 1.7 A, 1.8 A and 2.4 A, representing ten non-crystallographically related monomers. The enzyme is dimeric, and has a large hydrophobic core; each half of the molecule consists of a five-stranded beta-sheet surrounded by alpha-helices. Helices F and F protrude from the core region of each monomer. There is an extensive dimer interface, and the 15 C-terminal residues extend around the opposing monomer, contributing the fifth beta-strand. The active sites lie on opposite sides of the molecule, in solvent-exposed clefts at the dimer interface. The FMN forms hydrogen bonds to one monomer and hydrophobic contacts to both; its si face is buried. The nicotinic acid stacks between the re face of the FMN and Phe124 in helix F, with only one hydrogen bond to the protein. If the nicotinamide ring of the coenzyme NAD(P)H were in the same position as that of the nicotinic acid ligand, its C4 atom would be optimally positioned for direct hydride transfer to flavin N5. Comparison of the structure with unliganded flavin reductase and NTR suggests reduced mobility of helices E and F upon ligand binding. Analysis of the structure explains the broad substrate specificity of the enzyme, and provides the basis for rational design of novel prodrugs and for site-directed mutagenesis for improved enzyme activity.


==About this Structure==
==About this Structure==
1ICV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with FMN and NIO as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/6,7-dihydropteridine_reductase 6,7-dihydropteridine reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.5.1.34 1.5.1.34] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1ICV OCA].  
1ICV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=FMN:'>FMN</scene> and <scene name='pdbligand=NIO:'>NIO</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/6,7-dihydropteridine_reductase 6,7-dihydropteridine reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.5.1.34 1.5.1.34] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ICV OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Escherichia coli]]
[[Category: Escherichia coli]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Hyde, E.I.]]
[[Category: Hyde, E I.]]
[[Category: Lovering, A.L.]]
[[Category: Lovering, A L.]]
[[Category: Searle, P.F.]]
[[Category: Searle, P F.]]
[[Category: White, S.A.]]
[[Category: White, S A.]]
[[Category: FMN]]
[[Category: FMN]]
[[Category: NIO]]
[[Category: NIO]]
[[Category: alpha-beta]]
[[Category: alpha-beta]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 17:17:37 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:10:33 2008''

Revision as of 14:10, 21 February 2008

File:1icv.jpg


1icv, resolution 2.4Å

Drag the structure with the mouse to rotate

THE STRUCTURE OF ESCHERICHIA COLI NITROREDUCTASE COMPLEXED WITH NICOTINIC ACID

OverviewOverview

Escherichia coli nitroreductase is a flavoprotein that reduces a variety of quinone and nitroaromatic substrates. Its ability to convert relatively non-toxic prodrugs such as CB1954 (5-[aziridin-1-yl]-2,4-dinitrobenzamide) into highly cytotoxic derivatives has led to interest in its potential for cancer gene therapy. We have determined the structure of the enzyme bound to a substrate analogue, nicotinic acid, from three crystal forms at resolutions of 1.7 A, 1.8 A and 2.4 A, representing ten non-crystallographically related monomers. The enzyme is dimeric, and has a large hydrophobic core; each half of the molecule consists of a five-stranded beta-sheet surrounded by alpha-helices. Helices F and F protrude from the core region of each monomer. There is an extensive dimer interface, and the 15 C-terminal residues extend around the opposing monomer, contributing the fifth beta-strand. The active sites lie on opposite sides of the molecule, in solvent-exposed clefts at the dimer interface. The FMN forms hydrogen bonds to one monomer and hydrophobic contacts to both; its si face is buried. The nicotinic acid stacks between the re face of the FMN and Phe124 in helix F, with only one hydrogen bond to the protein. If the nicotinamide ring of the coenzyme NAD(P)H were in the same position as that of the nicotinic acid ligand, its C4 atom would be optimally positioned for direct hydride transfer to flavin N5. Comparison of the structure with unliganded flavin reductase and NTR suggests reduced mobility of helices E and F upon ligand binding. Analysis of the structure explains the broad substrate specificity of the enzyme, and provides the basis for rational design of novel prodrugs and for site-directed mutagenesis for improved enzyme activity.

About this StructureAbout this Structure

1ICV is a Single protein structure of sequence from Escherichia coli with and as ligands. Active as 6,7-dihydropteridine reductase, with EC number 1.5.1.34 Full crystallographic information is available from OCA.

ReferenceReference

The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 A, 1.8 A and 2.4 A resolution., Lovering AL, Hyde EI, Searle PF, White SA, J Mol Biol. 2001 May 25;309(1):203-13. PMID:11491290

Page seeded by OCA on Thu Feb 21 13:10:33 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA